Antidiabetic potential of Lysiphyllum strychnifolium (Craib) A. Schmitz compounds in human intestinal epithelial Caco-2 cells and molecular docking-based approaches

Antidiabetic potential of Lysiphyllum strychnifolium (Craib) A. Schmitz compounds in human intestinal epithelial Caco-2 cells and molecular docking-based approaches

Abstract Background Lysiphyllum strychnifolium (Craib) A. Schmitz, a traditional Thai medicinal plant, is mainly composed of polyphenols and flavonoids and exhibits several pharmacological activities, including antioxidant, anticancer, antimicrobial, and antidiabetic activities. However, the mechani...

Full description

Bibliographic Details
Main Authors: Kunwadee Noonong, Kanta Pranweerapaiboon, Kulathida Chaithirayanon, Kantamat Surayarn, Phicharinee Ditracha, Narin Changklungmoa, Pornanan Kueakhai, Poonsit Hiransai, Kingkan Bunluepuech
Format: Article
Language:English
Published: BMC 2022-09-01
Series:BMC Complementary Medicine and Therapies
Subjects:
L. strychnifolium
α-amylase
α-glucosidase
Caco-2 cell
Glucose transporters
Online Access:https://doi.org/10.1186/s12906-022-03706-x

Internet

https://doi.org/10.1186/s12906-022-03706-x

Similar Items